» Articles » PMID: 37893227

Cardioprotective Activity of Pharmacological Agents Affecting NO Production and Bioavailability in the Early Postnatal Period After Intrauterine Hypoxia in Rats

Overview
Journal Biomedicines
Date 2023 Oct 28
PMID 37893227
Authors
Affiliations
Soon will be listed here.
Abstract

Intrauterine hypoxia in newborns leads to a multifaceted array of alterations that exert a detrimental impact on the cardiovascular system. The aim of this research was to assess the cardioprotective effects of modulators of the nitric oxide (NO) system, including L-arginine, Thiotriazoline, Angiolin, and Mildronate, during the early postnatal period following intrauterine hypoxia. Methods: The study involved 50 female white rats. Pregnant female rats were given a daily intraperitoneal dose of 50 mg/kg of sodium nitrite starting on the 16th day of pregnancy. A control group of pregnant rats received saline instead. The resulting offspring were divided into the following groups: Group 1-intact rats; Group 2-rat pups subjected to prenatal hypoxia (PH) and daily treated with physiological saline; and Groups 3 to 6-rat pups exposed to prenatal hypoxia and treated daily from the 1st to the 30th day after birth. Nitrotyrosine levels, eNOS, iNOS, and NO metabolites were evaluated using ELISA; to measure the expression levels of iNOS mRNA and eNOS mRNA, a PCR test was utilized. Results: Angiolin enhances the expression of eNOS mRNA and boosts eNOS activity in the myocardium of rats with ischemic conditions. Arginine and particularly Thiotriazoline exhibited a consistent impact in restoring normal parameters of the cardiac nitroxidergic system following PH. Mildronate notably raised iNOS mRNA levels and notably reduced nitrotyrosine levels, providing further support for its antioxidative characteristics.

Citing Articles

Possibility of Using NO Modulators for Pharmacocorrection of Endothelial Dysfunction After Prenatal Hypoxia.

Belenichev I, Popazova O, Yadlovskyi O, Bukhtiyarova N, Ryzhenko V, Pavlov S Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861168 PMC: 11768627. DOI: 10.3390/ph18010106.


Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.

Belenichev I, Popazova O, Bukhtiyarova N, Ryzhenko V, Pavlov S, Suprun E Antioxidants (Basel). 2025; 14(1).

PMID: 39857442 PMC: 11760872. DOI: 10.3390/antiox14010108.


Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection.

Belenichev I, Popazova O, Bukhtiyarova N, Savchenko D, Oksenych V, Kamyshnyi O Antioxidants (Basel). 2024; 13(5).

PMID: 38790609 PMC: 11118938. DOI: 10.3390/antiox13050504.


Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children with Myocardial Changes.

Kamenshchyk A, Belenichev I, Oksenych V, Kamyshnyi O Biomolecules. 2024; 14(4).

PMID: 38672493 PMC: 11047929. DOI: 10.3390/biom14040477.


Hacking the Lipidome: New Ferroptosis Strategies in Cancer Therapy.

Varynskyi B, Schick J Biomedicines. 2024; 12(3).

PMID: 38540154 PMC: 10968238. DOI: 10.3390/biomedicines12030541.

References
1.
Rodriguez-Miguelez P, Lima-Cabello E, Martinez-Florez S, Almar M, Cuevas M, Gonzalez-Gallego J . Hypoxia-inducible factor-1 modulates the expression of vascular endothelial growth factor and endothelial nitric oxide synthase induced by eccentric exercise. J Appl Physiol (1985). 2015; 118(8):1075-83. DOI: 10.1152/japplphysiol.00780.2014. View

2.
Hula N, Liu R, Spaans F, Pasha M, Quon A, Kirschenman R . The Long-Term Effects of Prenatal Hypoxia on Coronary Artery Function of the Male and Female Offspring. Biomedicines. 2022; 10(12). PMC: 9776081. DOI: 10.3390/biomedicines10123019. View

3.
Filho B, da Costa B, Ogando P, Vieira M, Antonello I, Poli-de-Figueiredo C . Serum nitrate and NOx levels in preeclampsia are higher than in normal pregnancy. Hypertens Pregnancy. 2016; 35(2):226-33. DOI: 10.3109/10641955.2016.1139718. View

4.
Bilous I, Pavlovych L, Kamyshnyi A . Primary hypothyroidism and autoimmune thyroiditis alter the transcriptional activity of genes regulating neurogenesis in the blood of patients. Endocr Regul. 2021; 55(1):5-15. DOI: 10.2478/enr-2021-0002. View

5.
Jung F, Palmer L, Zhou N, Johns R . Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res. 2000; 86(3):319-25. DOI: 10.1161/01.res.86.3.319. View